We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Closing Heart Foramen Reduces Associated Migraines

By HospiMedica staff writers
Posted on 17 May 2006
Transcatheter closure of patent foramen ovale (PFO) abolishes right-to-left shunting and reduces aura migraine headaches, according to a new study. More...


Researchers from the University of Bologna (Italy) examined factors responsible for migraine headache with aura in patients with PFO and assessed the mechanisms through which PFO closure leads to an improvement in such headaches.
Although the mechanisms that link right-to-left shunt to headache are unknown, comparison between PFO patients without migraine headache to those with a headache showed the latter had a higher prevalence of spontaneous and Valsalva-induced right-to-left shunt and a higher prevalence of spontaneous large shunt, both in transesophageal echocardiography and in transcranial Doppler studies.

Patients with headache also had more complex atrial septal anatomy and more often had an associated thrombophilia than patients without headache, the results indicated. Thirty-two of 35 patients experienced either complete resolution or significant improvement in their headaches after the procedure. None of the three patients who did not improve after the procedure had a residual shunt at transesophageal echocardiography. The results were reported in the April 2006 issue of the American Heart Journal.

"Paradoxical embolization of small-sized venous thrombus or platelet aggregate reasonably seems to be the leading mechanism precipitating migraine headache with aura in patients with a PFO,” wrote Dr. Alessandro Giardini and colleagues. "Transcatheter defect closure seems to be an effective and safe means to treat migraine headache with aura in patients with PFO.”



Related Links:
University of Bologna

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.